RCMI Coordinating Center (RCMI CC) Header Logo

Connection

James Porter to Animals

This is a "connection" page, showing publications James Porter has written about Animals.
Connection Strength

0.899
  1. Irizarry-M?ndez N, Criado-Marrero M, Hernandez A, Col?n M, Porter JT. Reducing FKBP51 Expression in the Ventral Hippocampus Decreases Auditory Fear Conditioning in Male Rats. Int J Mol Sci. 2024 Jun 28; 25(13).
    View in: PubMed
    Score: 0.075
  2. Ortiz-Nazario E, Denton-Ortiz CM, Soto-Escobar LDM, Mateo-Mayol Z, Colon-Romero M, Hernandez-Lopez A, Porter JT. Sex-dependent effects of angiotensin II type 1 receptor blocker on molecular and behavioral changes induced by single prolonged stress. Behav Brain Res. 2023 10 02; 454:114639.
    View in: PubMed
    Score: 0.071
  3. Torres-Rodr?guez O, Rivera-Escobales Y, Castillo-Ocampo Y, Velazquez B, Col?n M, Porter JT. Purinergic P2X7 receptor-mediated inflammation precedes PTSD-related behaviors in rats. Brain Behav Immun. 2023 05; 110:107-118.
    View in: PubMed
    Score: 0.068
  4. Porter JT, Sepulveda-Orengo MT. Learning-induced intrinsic and synaptic plasticity in the rodent medial prefrontal cortex. Neurobiol Learn Mem. 2020 03; 169:107117.
    View in: PubMed
    Score: 0.055
  5. Soler-Cede?o O, Torres-Rodr?guez O, Bernard F, Maldonado L, Hern?ndez A, Porter JT. Plasticity of NMDA Receptors at Ventral Hippocampal Synapses in the Infralimbic Cortex Regulates Cued Fear. eNeuro. 2019 Mar-Apr; 6(2).
    View in: PubMed
    Score: 0.052
  6. Criado-Marrero M, Morales Silva RJ, Velazquez B, Hern?ndez A, Colon M, Cruz E, Soler-Cede?o O, Porter JT. Dynamic expression of FKBP5 in the medial prefrontal cortex regulates resiliency to conditioned fear. Learn Mem. 2017 04; 24(4):145-152.
    View in: PubMed
    Score: 0.045
  7. Soler-Cede?o O, Cruz E, Criado-Marrero M, Porter JT. Contextual fear conditioning depresses infralimbic excitability. Neurobiol Learn Mem. 2016 Apr; 130:77-82.
    View in: PubMed
    Score: 0.042
  8. Qui?ones MM, Maldonado L, Velazquez B, Porter JT. Candesartan ameliorates impaired fear extinction induced by innate immune activation. Brain Behav Immun. 2016 Feb; 52:169-177.
    View in: PubMed
    Score: 0.041
  9. Cruz E, Soler-Cede?o O, Negr?n G, Criado-Marrero M, Chompr? G, Porter JT. Infralimbic EphB2 Modulates Fear Extinction in Adolescent Rats. J Neurosci. 2015 Sep 09; 35(36):12394-403.
    View in: PubMed
    Score: 0.041
  10. Mateo Z, Porter JT. Developmental decline in modulation of glutamatergic synapses in layer IV of the barrel cortex by group II metabotropic glutamate receptors. Neuroscience. 2015 Apr 02; 290:41-8.
    View in: PubMed
    Score: 0.039
  11. Cruz E, L?pez AV, Porter JT. Spontaneous recovery of fear reverses extinction-induced excitability of infralimbic neurons. PLoS One. 2014; 9(8):e103596.
    View in: PubMed
    Score: 0.038
  12. Sepulveda-Orengo MT, Lopez AV, Soler-Cede?o O, Porter JT. Fear extinction induces mGluR5-mediated synaptic and intrinsic plasticity in infralimbic neurons. J Neurosci. 2013 Apr 24; 33(17):7184-93.
    View in: PubMed
    Score: 0.035
  13. Santini E, Sepulveda-Orengo M, Porter JT. Muscarinic receptors modulate the intrinsic excitability of infralimbic neurons and consolidation of fear extinction. Neuropsychopharmacology. 2012 Aug; 37(9):2047-56.
    View in: PubMed
    Score: 0.032
  14. Santini E, Porter JT. M-type potassium channels modulate the intrinsic excitability of infralimbic neurons and regulate fear expression and extinction. J Neurosci. 2010 Sep 15; 30(37):12379-86.
    View in: PubMed
    Score: 0.029
  15. Fontanez-Nuin DE, Santini E, Quirk GJ, Porter JT. Memory for fear extinction requires mGluR5-mediated activation of infralimbic neurons. Cereb Cortex. 2011 Mar; 21(3):727-35.
    View in: PubMed
    Score: 0.029
  16. Santini E, Quirk GJ, Porter JT. Fear conditioning and extinction differentially modify the intrinsic excitability of infralimbic neurons. J Neurosci. 2008 Apr 09; 28(15):4028-36.
    View in: PubMed
    Score: 0.024
  17. Mateo Z, Porter JT. Group II metabotropic glutamate receptors inhibit glutamate release at thalamocortical synapses in the developing somatosensory cortex. Neuroscience. 2007 May 25; 146(3):1062-72.
    View in: PubMed
    Score: 0.023
  18. Fontanez DE, Porter JT. Adenosine A1 receptors decrease thalamic excitation of inhibitory and excitatory neurons in the barrel cortex. Neuroscience. 2006; 137(4):1177-84.
    View in: PubMed
    Score: 0.021
  19. Porter JT, Nieves D. Presynaptic GABAB receptors modulate thalamic excitation of inhibitory and excitatory neurons in the mouse barrel cortex. J Neurophysiol. 2004 Nov; 92(5):2762-70.
    View in: PubMed
    Score: 0.019
  20. Porter JT, Johnson CK, Agmon A. Diverse types of interneurons generate thalamus-evoked feedforward inhibition in the mouse barrel cortex. J Neurosci. 2001 Apr 15; 21(8):2699-710.
    View in: PubMed
    Score: 0.015
  21. Porter JT, Cauli B, Tsuzuki K, Lambolez B, Rossier J, Audinat E. Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. J Neurosci. 1999 Jul 01; 19(13):5228-35.
    View in: PubMed
    Score: 0.013
  22. Porter JT, Cauli B, Staiger JF, Lambolez B, Rossier J, Audinat E. Properties of bipolar VIPergic interneurons and their excitation by pyramidal neurons in the rat neocortex. Eur J Neurosci. 1998 Dec; 10(12):3617-28.
    View in: PubMed
    Score: 0.013
  23. Porter JT, McCarthy KD. Astrocytic neurotransmitter receptors in situ and in vivo. Prog Neurobiol. 1997 Mar; 51(4):439-55.
    View in: PubMed
    Score: 0.011
  24. Porter JT, McCarthy KD. Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals. J Neurosci. 1996 Aug 15; 16(16):5073-81.
    View in: PubMed
    Score: 0.011
  25. Porter JT, McCarthy KD. Adenosine receptors modulate [Ca2+]i in hippocampal astrocytes in situ. J Neurochem. 1995 Oct; 65(4):1515-23.
    View in: PubMed
    Score: 0.010
  26. Porter JT, McCarthy KD. GFAP-positive hippocampal astrocytes in situ respond to glutamatergic neuroligands with increases in [Ca2+]i. Glia. 1995 Feb; 13(2):101-12.
    View in: PubMed
    Score: 0.010
  27. V?zquez-Santiago FJ, Noel RJ, Porter JT, Rivera-Amill V. Glutamate metabolism and HIV-associated neurocognitive disorders. J Neurovirol. 2014 Aug; 20(4):315-31.
    View in: PubMed
    Score: 0.009
  28. Chompre G, Cruz E, Maldonado L, Rivera-Amill V, Porter JT, Noel RJ. Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory. Neurobiol Dis. 2013 Jan; 49:128-36.
    View in: PubMed
    Score: 0.008
  29. Mueller D, Porter JT, Quirk GJ. Noradrenergic signaling in infralimbic cortex increases cell excitability and strengthens memory for fear extinction. J Neurosci. 2008 Jan 09; 28(2):369-75.
    View in: PubMed
    Score: 0.006
  30. Kooncumchoo P, Sharma S, Porter J, Govitrapong P, Ebadi M. Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons. J Mol Neurosci. 2006; 28(2):125-41.
    View in: PubMed
    Score: 0.005
  31. Wells JE, Porter JT, Agmon A. GABAergic inhibition suppresses paroxysmal network activity in the neonatal rodent hippocampus and neocortex. J Neurosci. 2000 Dec 01; 20(23):8822-30.
    View in: PubMed
    Score: 0.004
  32. Cauli B, Porter JT, Tsuzuki K, Lambolez B, Rossier J, Quenet B, Audinat E. Classification of fusiform neocortical interneurons based on unsupervised clustering. Proc Natl Acad Sci U S A. 2000 May 23; 97(11):6144-9.
    View in: PubMed
    Score: 0.004
  33. Shao Y, Porter JT, McCarthy KD. Neuroligand receptor heterogeneity among astroglia. Perspect Dev Neurobiol. 1994; 2(3):205-15.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support